Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00369616
Status:
COMPLETED
Last Update Posted:
2010-11-15
First Post:
2006-08-25
Brief Title:
Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers
Sponsor:
Cytos Biotechnology AG
Organization:
Cytos Biotechnology AG
Study Overview
Official Title:
Evaluation of Efficacy and Safety of Nicotine-Qbeta NicQb Vaccine Versus Placebo in Healthy Smokers
Status:
COMPLETED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to help smokers quitting by vaccinating them with CYT002-NicQb Upon vaccination the smoker will generate antibodies directed against free nicotine The antibodies will bind nicotine and prevent its passage into the brain The successfully vaccinated smoker will have no reward effect after smoking thus braking the vicious circle of nicotine addiction
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None